117 related articles for article (PubMed ID: 1359539)
1. Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor.
Epstein RJ; Druker BJ; Roberts TM; Stiles CD
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10435-9. PubMed ID: 1359539
[TBL] [Abstract][Full Text] [Related]
2. Preferential detection of catalytically inactive c-erbB-2 by antibodies to unphosphorylated peptides mimicking receptor tyrosine autophosphorylation sites.
Epstein RJ
Oncogene; 1995 Jul; 11(2):315-23. PubMed ID: 7624146
[TBL] [Abstract][Full Text] [Related]
3. Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active.
Yarden Y
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2569-73. PubMed ID: 1969636
[TBL] [Abstract][Full Text] [Related]
4. Signal transduction by the neu/erbB-2 receptor: a potential target for anti-tumor therapy.
Stancovski I; Peles E; Ben Levy R; Lemprecht R; Kelman Z; Goldman-Michael R; Hurwitz E; Bacus S; Sela M; Yarden Y
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):95-103. PubMed ID: 1356018
[TBL] [Abstract][Full Text] [Related]
5. The transforming potential of the c-erbB-2 protein is regulated by its autophosphorylation at the carboxyl-terminal domain.
Akiyama T; Matsuda S; Namba Y; Saito T; Toyoshima K; Yamamoto T
Mol Cell Biol; 1991 Feb; 11(2):833-42. PubMed ID: 1671296
[TBL] [Abstract][Full Text] [Related]
6. TPA inhibits the tyrosine kinase activity of the neu protein in vivo and in vitro.
Cao H; Decker S; Stern DF
Oncogene; 1991 May; 6(5):705-11. PubMed ID: 1675782
[TBL] [Abstract][Full Text] [Related]
7. Biological effects of monoclonal antireceptor antibodies reactive with neu oncogene product, p185neu.
Myers JN; Drebin JA; Wada T; Greene MI
Methods Enzymol; 1991; 198():277-90. PubMed ID: 1677444
[No Abstract] [Full Text] [Related]
8. Preparation and application of antibodies to phosphoamino acid sequences.
Sun T; Campbell M; Gordon W; Arlinghaus RB
Biopolymers; 2001; 60(1):61-75. PubMed ID: 11376433
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.
Wahl MI; Fluckiger AC; Kato RM; Park H; Witte ON; Rawlings DJ
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11526-33. PubMed ID: 9326643
[TBL] [Abstract][Full Text] [Related]
10. The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand.
Lonardo F; Di Marco E; King CR; Pierce JH; Segatto O; Aaronson SA; Di Fiore PP
New Biol; 1990 Nov; 2(11):992-1003. PubMed ID: 1983208
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed Drosophila src 64B is phosphorylated at its carboxy-terminal tyrosine, but is not catalytically repressed, in cultured Drosophila cells.
Kussick SJ; Cooper JA
Oncogene; 1992 Dec; 7(12):2461-70. PubMed ID: 1281305
[TBL] [Abstract][Full Text] [Related]
12. Antiserum raised against a synthetic phosphotyrosine-containing peptide selectively recognizes p185neu/erbB-2 and the epidermal growth factor receptor.
Bangalore L; Tanner AJ; Laudano AP; Stern DF
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11637-41. PubMed ID: 1280833
[TBL] [Abstract][Full Text] [Related]
13. The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade.
Connelly PA; Stern DF
Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6054-7. PubMed ID: 1974718
[TBL] [Abstract][Full Text] [Related]
14. Active c-erbB-2 induces short-term growth of FDC-P2 cells after IL-3 depletion.
Wongsasant B; Matsuda S; Yamamoto T
Biochem Biophys Res Commun; 1991 Dec; 181(3):981-8. PubMed ID: 1684897
[TBL] [Abstract][Full Text] [Related]
15. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
[TBL] [Abstract][Full Text] [Related]
16. Site-specific anti-phosphopeptide antibodies: use in assessing insulin receptor serine/threonine phosphorylation state and identification of serine-1327 as a novel site of phorbol ester-induced phosphorylation.
Coghlan MP; Pillay TS; Tavaré JM; Siddle K
Biochem J; 1994 Nov; 303 ( Pt 3)(Pt 3):893-9. PubMed ID: 7980459
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of monoclonal antibodies to the c-erbB-2 proto-oncogene protein using a synthetic peptide immunogen.
Tuzi NL; Venter DJ; Reidlinger JA; Dean CJ; Gullick WJ
Biochem Soc Trans; 1988 Oct; 16(5):675-7. PubMed ID: 2906884
[No Abstract] [Full Text] [Related]
18. Anti-receptor antibodies reverse the phenotype of cells transformed by two interacting proto-oncogene encoded receptor proteins.
Wada T; Myers JN; Kokai Y; Brown VI; Hamuro J; LeVea CM; Greene MI
Oncogene; 1990 Apr; 5(4):489-95. PubMed ID: 1970151
[TBL] [Abstract][Full Text] [Related]
19. The role of autophosphorylation in modulation of erbB-2 transforming function.
Segatto O; Lonardo F; Pierce JH; Bottaro DP; Di Fiore PP
New Biol; 1990 Feb; 2(2):187-95. PubMed ID: 1982072
[TBL] [Abstract][Full Text] [Related]
20. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
Kamps MP; Sefton BM
Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
